Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Benchmarking cancer outcomes in Europe: a scoping review of methodologies and case-mix adjustments.
ESMO real world data and digital oncology·2026
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
[Rare manifestations of giant cell arteritis].
Lakartidningen·2026
[Neoehrlichiosis in rituximab-treated patients with MS in Sweden].
Lakartidningen·2026
[Postoperative atrial fibrillation after open heart surgery].
Lakartidningen·2026
[Interaction between psychotic patients and AI-driven chatbots].
Lakartidningen·2026